ID ASPD_PSYCK Reviewed; 263 AA. AC Q1QBB6; DT 05-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 16-MAY-2006, sequence version 1. DT 04-NOV-2008, entry version 20. DE RecName: Full=Probable L-aspartate dehydrogenase; DE EC=1.4.1.21; GN Name=nadX; OrderedLocusNames=Pcryo_1256; OS Psychrobacter cryohalolentis (strain K5). OC Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales; OC Moraxellaceae; Psychrobacter. OX NCBI_TaxID=335284; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C., Glavina T., RA Hammon N., Israni S., Dalin E., Tice H., Pitluck S., Brettin T., RA Bruce D., Han C., Tapia R., Sims D.R., Gilna P., Schmutz J., RA Larimer F., Land M., Hauser L., Kyrpides N., Kim E., Richardson P.; RT "Complete sequence of chromosome of Psychrobacter cryohalolentis K5."; RL Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Specifically catalyzes the NAD or NADP-dependent CC dehydrogenation of L-aspartate to iminoaspartate (By similarity). CC -!- CATALYTIC ACTIVITY: L-aspartate + H(2)O + NAD(P)(+) = oxaloacetate CC + NH(3) + NAD(P)H. CC -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; CC iminoaspartate from L-aspartate (dehydrogenase route): step 1/1. CC -!- MISCELLANEOUS: The iminoaspartate product is unstable in aqueous CC solution and can decompose to oxaloacetate and ammonia (By CC similarity). CC -!- SIMILARITY: Belongs to the L-aspartate dehydrogenase family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CP000323; ABE75037.1; -; Genomic_DNA. DR RefSeq; YP_580521.1; -. DR GeneID; 4034285; -. DR GenomeReviews; CP000323_GR; Pcryo_1256. DR KEGG; pcr:Pcryo_1256; -. DR NMPDR; fig|335284.3.peg.838; -. DR HOGENOM; Q1QBB6; -. DR BioCyc; PCRY335284:PCRYO_1256-MON; -. DR GO; GO:0051287; F:NAD binding; IEA:HAMAP. DR GO; GO:0050661; F:NADP binding; IEA:HAMAP. DR GO; GO:0016639; F:oxidoreductase activity, acting on the CH-N...; IEA:HAMAP. DR GO; GO:0009435; P:NAD biosynthetic process; IEA:HAMAP. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR HAMAP; MF_01265; -; 1. DR InterPro; IPR005106; Asp/hSer_DHase_NAD-bd. DR InterPro; IPR002811; Asp_DHase. DR InterPro; IPR011182; Asp_DHase_NAD_syn. DR Pfam; PF01958; DUF108; 1. DR Pfam; PF03447; NAD_binding_3; 1. DR PIRSF; PIRSF005227; Asp_dh_NAD_syn; 1. DR ProDom; PD017325; Asp_dh; 1. PE 3: Inferred from homology; KW Complete proteome; NAD; NADP; Oxidoreductase; KW Pyridine nucleotide biosynthesis. FT CHAIN 1 263 Probable L-aspartate dehydrogenase. FT /FTId=PRO_1000067311. FT ACT_SITE 216 216 By similarity. FT BINDING 120 120 NAD; via amide nitrogen (By similarity). FT BINDING 186 186 NAD (By similarity). SQ SEQUENCE 263 AA; 27858 MW; 47927F6132E01CA0 CRC64; MKNVMFIGYG SMARKVHEML PKNIILSTVL VSTRSAEIIK TELGESIAVI TSVDDLIETP DLAVEMSGQD GLKEHAIKIL GKSIPLGIIS VGAFTDEKFA ISLADTAEAN GVEIHILAGA VAGIDGIHAA SFAGLSDVVY QGKKHPSSWK GSHADRLIDY DNLVEPTVFF TGTAREAAAL FPDNSNVAAT IAIAGVGLDD TTVELIADPT LEYNIHHIMA KGVFGKLEIS MAGLPLVENP KTSSLAAFSA LRLCCQIDQV IQM //